N-type calcium channels play an important role in synaptic transmission and a drug that blocks these channels has become an important tool in controlling chronic pain. The development of new N-channel-targeted drugs is dependent on a better understanding of the gating of these channels and how that gating can be modulated. We have previously concluded that ω-conotoxin GVIA (GVIA) is a gating modifier that acts by destabilizing the N-channel open state. However, this conclusion was largely based on our modeling results and requires experimental support. Roscovitine, a tri-substituted purine, has been shown to stabilize the N-channel open state to slow gating charge relaxation, which provides a direct test of our hypothesis for GVIA-induced gating modification. We found that roscovitine could modulate gating current in the presence of GVIA, which shows that roscovitine can still affect the gating of the GVIA-bound N-channel. However, the magnitude of the roscovitineinduced slowing of Off-gating current was significantly reduced. In addition to confirming our hypothesis, our evidence supports an additional effect of GVIA to alter gating transitions between N-channel closed states. By strongly limiting access to the N-channel open state, GVIA analogs that selectively induce this modulation could provide the basis for the next generation drugs that treat chronic pain.
Introduction
N-type calcium channels play an important role in the central and peripheral nervous systems by controlling neurotransmission [1] [2] [3] . These channels mediate the neurotransmission of pain signals in the spinal cord, which makes the N-channel a desirable target for the treatment of chronic pain [4] [5] [6] [7] . There is currently only one drug that targets N-type channels [6, 8, 9] , Prialt, that has been approved by the FDA for chronic pain treatment. Prialt is a synthetic version of ω-conotoxin MVIIA that has proven to be extremely effective from treating some patients, but others have experienced serious side effects including dizziness, confusion and death [6] [7] [8] [9] [10] . Thus, it is important to find additional N-channel blockers that can expand the number of patients benefiting from this type of treatment.
Prialt and related peptides such as ω-conotoxin GVIA (GVIA) are thought to block N-type channels by plugging the pore [11] [12] [13] [14] , but we recently demonstrated that GVIA could also modify N-channel gating [15] . We demonstrated that GVIA accelerated N-channel gating charge movement and our theoretical simulations showed that gating modification alone (no pore block) would reduce action potential-induced Ca 2+ influx via N-channels by ∼50% [15] . Our modeling also led us to conclude that GVIA modulates N-channel gating by destabilizing the open state [15] . However, it is critical to support this conclusion with experimental data, which is difficult because of the complete pore block induced by this toxin. Roscovitine is a tri-substituted purine that slows N-channel closing by stabilizing the open state [16] [17] [18] [19] . One result of this stabilization is that Off-gating charge movement is slowed so that it appears that the gating charge cannot move until the channel begins to close [20] . The discovery of roscovitine-slowed Off-gating charge movement provides us with the experimental opportunity to test our hypothesis that GVIA affects gating by destabilizing the open state.
Based on our previous work, we predicted that the GVIAdestabilization of the open state would profoundly reduce the effect of roscovitine on Off-gating current, and our experimental results fully support this prediction. Our conclusion that GVIA destabilizes the Nchannel open state is also supported by new simulations with our model that has been updated to more accurately reproduce our gating current data [20] . However, this model supports an additional effect of GVIA to speed closed-closed transitions. Our modeling shows that one common feature of GVIA-induced changes to N-channel gating appears to be an increased relaxation speed of each voltage sensor involved in channel activation [15] .
Materials and methods

HEK cell transfection
We utilized the calcium phosphate precipitation method to transfect HEK293 cells with α 1B-CFP (CaV2.2), α 2 δ, and β 2a subunits as described previously [21] . α 1B-CFP (GenBank™ number AF055477) contained CFP encoding cDNA attached to N-terminus of α 1B , which was used to fluorescently identify transfected cells. HEK293 cells were maintained in standard DMEM/Glutamax® medium containing 10% fetal bovine serum and 1% antibiotic-antimycotic at 37°C in 5% CO 2 incubator. We specifically chose the CaVβ 2a subunit to limit the inhibition induced by roscovitine [20] . We recently demonstrated that this inhibition results from roscovitine driving N-channels into closed-state inactivation [17] , and occupancy of this state is abrogated by co-expression of the β 2a subunit [20] , which allows us to study the roscovitine-induced slowed N-channel closing in isolation from the other effect.
Measurement of gating currents
Cells were voltage-clamped using the whole-cell configuration of the patch clamp technique. Pipettes were pulled from Schott 8250 glass (Garner Glass, Claremont, CA) on a Sutter P-97 puller (Sutter Instruments Co., Novato, CA). Currents were recorded using an Axopatch 200A amplifier (Molecular Devices, Sunnyvale, CA) and digitized with ITC-18 data acquisition interface (Instrutech Corporation, Port Washington, NY). Experiments were controlled by a Power Macintosh G3 computer (Apple Computer, Cupertino, CA) running S5 data acquisition software written by Dr. Stephen Ikeda (NIH, NIAAA, Bethesda, MD). Leak current was subtracted online using a −P/8 protocol as previously described [15] . All recordings were carried out at room temperature and the holding potential was −120 mV. Gating currents were digitized at 50 kHz after analog filtering at 10 kHz using 40%-60% series resistance compensation leaving a maximum voltage-clamp error of b5 mV. There was no correlation between gating current parameters and maximum voltage error and/or series resistance [15] .
As previously described [15] , we isolated gating currents by using a lanthanum and magnesium (LaMg) external solution containing (in mM): 0.2 LaCl 3 , 5 MgCl 2 , 0.1 N-methyl-D-glucamine (NMG)-EGTA, 145 NMG-Cl, 10 NMG-HEPES with osmolarity = 325 mOsm and pH = 7.4. In LaMg, the free [La 3+ ] was 0.1 mM since 1/2 the La 3+ was chelated by 0.1 mM EGTA [22] [23] [24] . We added 5 µM GVIA to this solution to make LaMg-GVIA. R-roscovitine (roscovitine) was prepared as a 50 mM stock solution in DMSO and stored at −30°C. The 50 mM stock was diluted into the LaMg and LaMg-GVIA solutions to make a final concentration of 100 µM roscovitine. DMSO was added to the control solutions so that the DMSO concentration (0.2%) was identical in all external solutions. Test solutions were applied from a gravity-fed perfusion system with an exchange time of 1-2 s.
Data analysis
Data were analyzed using IgorPro (WaveMetrics, Lake Oswego, OR) running on a Macintosh computer. Gating currents were filtered using an IgorPro binomial smooth function, which is a Gaussian filter with a 2.3 kHz cutoff. This filtering did not noticeably change the gating current waveform but greatly improved the signal-to-noise ratio. Small steady state currents introduced by the −P/8 leak subtraction protocol were measured at the end of the voltage step and subtracted from gating currents [15] . The charge (Q) moved by depolarization or repolarization (Q On or Q Off , respectively) was calculated by integrating gating currents over the entire voltage step. The Q vs. voltage (V) curve was fitted by a single Boltzmann function to yield the half maximal voltage (V 0.5 ), slope factor (k), and maximum Q (Q max ). The On-(τQ On ) and Off-(τQ Off ) gating current time constants (τs) were determined by fitting gating current with a single exponential equation [15] . We have previously utilized double exponential fitting of ionic current to examine the effect of roscovitine and its analogs on tail currents [17, 18] . However, these papers investigated sub-maximal effects of these drugs so that the channels existed in both the roscovitine-bound and unbound states. Here we are using a near maximal roscovitine concentration (100 µM) so that nearly all activated channels will be in the roscovitine-bound state [17] , which is the reason single exponential fitting of roscovitineslowed Off-gating current provided excellent correspondence (see Fig. 1 ). Group data were calculated as mean ± SD throughout the paper. Paired T-test was used for within-cell comparisons. One-way ANOVA with the Newman-Keuls posthoc test was used to test for differences among three or more independent groups.
Computer simulations
Simulated currents were generated using Axovacs 3 (written by Stephen W. Jones, Case Western Reserve University) on a Macintosh G4 computer running Virtual PC 6 (Microsoft, Inc, Seattle, WA). Voltage-dependent rate constants (k x ) in the model were calculated from:
where A x is the rate constant at 0 mV, z x is the charge moved, and R, T, F are the gas constant, absolute temperature and Faraday's constant, respectively (see Table 1 for A x and z x values). Simulated currents were analyzed using IgorPro.
Chemicals
All experiments utilized R-roscovitine from LC Labs (Woburn, MA) and GVIA from Bachem, Inc. (King of Prussia, PA). Cell culture materials were from Invitrogen (Carlsbad, CA). Other chemicals were obtained from Sigma (St. Louis, MO).
Results
We used roscovitine to probe N-channel gating currents in control and in the presence of GVIA to test our hypothesis that GVIA destabilizes the N-channel open state. Roscovitine slows Off-gating current [20] and we predicted that this effect would be significantly reduced by GVIA. All gating currents were recorded in lanthanum and magnesium (LaMg) ± 5 µM GVIA. This GVIA concentration was chosen to obtain a block of N-type channels that was sufficiently rapid to allow within-cell comparisons that would make the effect of GVIA and roscovitine much easier to interpret [15] . This concentration is specific for N-type channels since we found no effect of 5 µM GVIA on gating currents generated by L-type channels (CaV1.2) (n = 4, not shown). The effect of roscovitine is illustrated in Fig. 1A . As we recently demonstrated [20] , the On-gating current observed at the beginning of the voltage step shows little if any effect in response to 100 µM roscovitine, while the Off-gating current is dramatically slowed and peak current is reduced (Fig. 1A, C) , as expected for a fixed amount of charge moving over a longer time. In the presence of GVIA, the On-gating current is not affected at this voltage as we previously demonstrated [15] , but Off-gating current is significantly accelerated (Fig. 1B, C) . While roscovitine can significantly slow Off-gating current in the presence of GVIA, the change in τQ Off is significantly reduced compared to that in LaMg (Fig. 1C, D) . The ability of roscovitine to affect gating implies that GVIA does not prevent roscovitine binding to the channel, but the reduced effect supports our hypothesis that GVIA destabilizes the N-channel open state.
Roscovitine induced a left-shift in the voltage-dependence of Nchannel activation as determined by Boltzmann equation fits (V 0.5 ) to the ionic current activation vs. voltage (V) relationship (∼−10 mV) and this shift was also observed in the gating charge (Q) vs. V relationship, but to a smaller degree (∼−4 mV) [20] . In the presence of GVIA, roscovitine induced a small, but significant (p b 0.05, T-test), left-shifted in the Q On -V and Q Off -V relationships (Fig. 2) . The roscovitine-induced shift in V 0.5 (ΔV 0.5 ) was not significantly different when compared between LaMg and LaMg + GVIA (Fig. 2C, D, E) . The Boltzmann slope factor was not significantly altered by roscovitine in LaMg ± GVIA (Fig. 2C , D, F) [20] . The absence of a GVIA-induced change in the roscovitine effect on V 0.5 further supports our conclusion that GVIA does not prevent roscovitine binding to the N-type channels.
Previously we established that channel opening was required to observe roscovitine-induced slow deactivation [16, 18] . Consistent with this idea, we found that the roscovitine effect on Q Off kinetics was strongly voltage-dependent as expected from open state-dependent roscovitine binding (Figs. 2A, 3 ) [20] . Qualitatively, GVIA appeared to shift the roscovitine effect on Q Off to more depolarized voltages (cf. Fig. 2A and B), which is expected from the ∼10 mV right-shift in the Q-V relationship induced by the toxin (Fig. 2C, D) [15] . The effect of GVIA on the voltage-dependence of roscovitine-slowed Q Off was quantified by determining τQ Off from single exponential fitting of the Off-gating current generated from the Q-V protocol and calculating the roscovitine-induced change in τQ Off (ΔτQ Off ) in GVIA. The data in LaMg were previously published [20] so we are showing a single exponential fit to those data here (Fig. 3A) . A plot of ΔτQ Off vs. step voltage (Fig. 3A) showed the dramatic suppression of roscovitineinduced slowing of Q Off illustrated in Figs. 1 and 2. However, the GVIAinduced suppression of the roscovitine effect on τQ Off made it difficult to quantify the degree to which GVIA shifted the voltage-dependence of the roscovitine effect. From Fig. 2B it seemed that the roscovitinereduction of peak Off-gating current would be a more sensitive measure of this effect. The magnitude of peak Off-gating current (I Cntl and I Rosc in control and roscovitine, respectively) was determined from the single exponential fitting of Off-gating currents used to determine τQ Off (Fig. 3A) . The ratio of peak Off-gating current in roscovitine vs. control (I Rosc /I Cntl ) nicely illustrates the impact of GVIA on the voltage-dependence of the roscovitine effect on Off-gating current (Fig 3B) . The I Rosc /I Cntl ratio was plotted vs. step voltage and fit using a single Boltzmann equation (Fig. 3B ), which yielded a V 0.5 in GVIA that was 32 mV more depolarized than that measured in LaMg [20] . The V 0.5 for the I Rosc /I Cntl ratio in LaMg (no GVIA) was −18 mV (slope factor = e-fold for −9 mV), which was depolarized to V 0.5 = 14 mV (slope factor = e-fold for −7 mV) by the addition of 5 µM GVIA. This shift is even larger than the GVIA-induced depolarizing shift in the Q-V relationship (∼ 10 mV) [15] and further supports the strong effect of GVIA to disrupt the N-channel open state.
To this point we have used only a narrow voltage range (−50 and −60 mV) to examine the effect of GVIA on roscovitine-slowed Off-gating Fig. 1 . Roscovitine-induced change in Off-gating current is decreased by GVIA. (A) Gating currents are shown in the absence of GVIA (LaMg) to illustrate the effect of 100 µM roscovitine (Rosc, black trace). Note the smaller peak Off-gating current and slower gating current relaxation at −50 mV. (B) The addition of GVIA to LaMg (+GVIA) accelerates Offgating currents in the absence of roscovitine, and also has a dramatic impact in the presence of 100 µM roscovitine (Rosc, black trace). (C) Single exponential fitting was used to determine τQ Off at −50 mV following voltage steps to +80 mV (see smooth gray lines superimposed on the Off-gating currents in panels A and B). Mean τQ Off ± SD is shown for Off-gating currents measured in LaMg and after the addition of 5 µM GVIA (+GVIA). For each bar "C" indicates control (i.e. no roscovitine) and "R" indicates the presence of 100 µM roscovitine. Data from five cells were averaged (within-cell comparisons for all treatments) and the small letters above each bar indicate significant differences (p b 0.05, ANOVA, Newman-Keuls posthoc analysis). (D) The percentage increase in τQ Off induced by 100 µM roscovitine is plotted from the data shown in panel C. The asterisk indicates that the change is significantly different from zero and the horizontal bracket indicates that the roscovitine-induced change is significantly different between LaMg and GVIA (p b 0.05, ANOVA, Newman-Keuls posthoc analysis). Table 1 Rate parameters for N-channel model. .
-indicates voltageindependent rate constants (i.e. no charge moved).
current. However, we have previously demonstrated that roscovitine slows Off-gating current at all voltages and this has provided critical data for model development [20] . The voltage-dependence of τQ Off was determined over a range of "tail" voltages (−10 to −140 mV) following a 10-ms step to +60 mV (Fig. 4A) . Data from LaMg were published previously and are depicted here (Fig. 4B) as smooth lines representing single exponential fits to the τQ Off vs. voltage relationship [20] . These single exponential fits generate a constant (Ve) representing the voltage-dependence of τQ Off , which is plotted in Fig. 4C for all conditions considered here. Under control conditions (no roscovitine), GVIA significantly reduces τQ Off at voltages ranging from −10 to −70 mV, which results from a 20 mV shift in the τQ Off vs. V relationship [20] . At voltages hyperpolarized to −70 mV, τQ Off appears to reach a voltageindependent plateau that motivated us to introduce a voltageindependent gating transition in our recent N-channel model update [20] . In roscovitine, GVIA has a profound effect on Off-gating current over the entire voltage range to significantly reduce τQ Off relative to that in LaMg (p b 0.05, T-test) (Fig. 4B) . The τQ Off Ve in roscovitine was significantly reduced by GVIA so that there was no longer any difference with control (GVIA alone), unlike the effect of roscovitine in LaMg (Fig. 4C) .
Markov model
In our previous study we were able to qualitatively reproduce the effect of GVIA on N-channel gating by adjusting only rate constants associated with the open state [15] . That model was based solely on whole-cell data, and the qualitative agreement with the experimental data was satisfactory for our initial description of the GVIA effect. However, our further investigation of gating currents required a model that provided better agreement with the experimental results, which motivated us to generate the model shown in Scheme 1 [20] . (C) Typical Q On -V relationships from the same cell for On-gating current in LaMg and LaMg + 5 µM GVIA (+GVIA) with (Rosc, black symbols) and without (Cntl, gray symbols) 100 µM roscovitine. The smooth curves are Boltzmann equation fits to the Q On -V relationships with V 0.5 = −11.7 mV, slope factor = 8.3 for LaMg and V 0.5 = −16.1 mV, slope factor= 9.1 for LaMg in roscovitine, and V 0.5 = 2.5 mV, slope factor = 13.0 for LaMg + GVIA and V 0.5 = −2.9 mV, slope factor = 13.6 for LaMg+ GVIA in roscovitine. Q On was normalized (norm) to the Q max value obtained from Boltzmann fitting. (D) Q Off -V relationships are presented as described for panel C. The smooth curves are Boltzmann equation fits to the Q Off -V relationships with V 0.5 = −7.4 mV, slope factor = 9.3 for LaMg and V 0.5 = −13.8 mV, slope factor = 9.0 for LaMg in roscovitine, and V 0.5 = 1.2 mV, slope factor = 11.1 for LaMg+ GVIA and V 0.5 = −4.4 mV, slope factor= 11.7 for LaMg + GVIA in roscovitine. (E) The average roscovitine-induced shift in V 0.5 (ΔV 0.5 ) ± SD is shown for both Q On and Q Off in LaMg (Gray bars) and LaMg + GVIA (open bars). The data are from the same 4 cells and the shift induced by roscovitine in LaMg is not significantly different from that in LaMg+ GVIA (ANOVA, Newman-Keuls posthoc analysis). (F) The average roscovitine-induced shift in Boltzmann slope factor (Δk) ± SD is shown as described for panel D. There are no significant differences among these data (ANOVA, Newman-Keuls posthoc analysis).
Scheme 1.
This model gave very good agreement between simulated and experimental gating current results for both control and 100 µM roscovitine [20] . The essential differences from our earlier model were the addition of two closed states along the pathway to channel opening and making the transition rates between C 4 and C 5 voltageindependent (indicated by the asterisks in Scheme 1). The reasons for introducing this transition and its placement are discussed in Yarotskyy and Elmslie [20] . As a first step, we needed to determine if our previous conclusion that GVIA only alters open state rate constants was valid for this new model. We made changes to the open state rate constants (k 56 , k 65 , k 67 , k 76 , Table 1 model GVIA1) that were similar to the adjustments made in our previous model [15] , and with these changes we were able to achieve good agreement with the effect of GVIA on the Q-V and the τQ Off -V relationships (Fig. 5A, B) . However, the simulated τQ On data from this model were not affected by GVIA as strongly as our experimental results (Fig. 5C ). On the other hand, additional simulations with the GVIA1 model using roscovitine demonstrated good agreement with our experimental data (Fig. 6D , open gray circles), so these model parameters were retained for the next model (GVIA2) in which we made additional adjustments to address the difference with the τQ On data. Since rather drastic changes to the open state rate constants had little effect on τQ On , we focused on closed-state transitions. From this process, we found good agreement with our experimental results if the toxin also increased the backward rate constants between voltage-dependent closed states (k 21 , k 32 , k 43 , Table 1 model GVIA2). The results from this model simulation are presented in Fig. 6 . We obtained good agreement with the experimental Q-V relationship both with and without roscovitine. Indeed, our correspondence was better near the foot of the Q-V curve in GVIA than with the open state only model (GVIA1) (cf. Figs. 5A and 6A) . The voltage-dependence of τQ Off is nicely reproduced by the GVIA2 model with a strong reduction of the roscovitine effect by GVIA (Fig. 6B ). This new model also addressed the problem with τQ On since GVIA has a strong effect at voltages b20 mV, but minimal effect at more depolarized voltage as we observed in our experimental results (Fig. 6C) . One key observation is the effect of GVIA on the voltage-dependent effect of roscovitine on Off-gating current. Model simulations show a strong right-shift in this voltage-dependent effect by GVIA with V 0.5 shifting + 29 mV (Fig. 6D) , which is close to the +32 mV shift measured from our experimental data. Our simulations also demonstrated that, consistent with our original prediction, the disruption of the roscovitine effect by GVIA is mediated by the effect of the toxin on the N-channel Fig. 3 . Stronger depolarization is required for roscovitine to affect Off-gating current in GVIA. (A) ΔτQ Off was calculated as the difference in τQ Off measured ± roscovitine in GVIA (black squares, n =4). The smooth line is a fit to ΔτQ Off in LaMg (±roscovitine, no GVIA) from Yarotskyy and Elmslie [20] . τQ Off was measured at −60 mV following voltage steps ranging from −120 to +80 mV (same protocol used to the generate Q-V relationships shown in Fig. 2 ) and ΔτQ Off is plotted vs. step voltage. (B) Peak Off-gating current was measured at −60 mV following voltage steps ranging from −120 to +80 mV (same protocol used for data of panel A) without (I Cntl , average of control and washout data) and with 100 µM roscovitine (I Rosc ). The I Rosc /I Cntl ratio (black squares, n = 4) is plotted vs. step voltage and the smooth line is from a Boltzmann equation fit with V 0.5 = 14.1 mV and slope factor e-fold for 7.3 mV. The smooth gray line is from a Boltzmann equation fit to I Rosc /I Cntl data in LaMg (no GVIA) that was previously published [20] with V 0.5 = −18.0 mV and slope factor= e-fold for 9.1 mV. open state since the right-shift of the I Rosc /I Cntl ratio is identical for both models (cf. Fig. 6D , superimposed open gray circles (GVIA1) and black squares (GVIA2)). Thus, our experimental and simulation results fully support our hypothesis that GVIA disrupts the N-channel open state.
Discussion
GVIA is assumed to block N-type calcium current by plugging the pore [11] [12] [13] [14] , but we recently found that this toxin can also modulate N-channel gating currents [15] . Roscovitine slows N-channel closing by stabilizing the open state [16] [17] [18] [19] , which also slows gating current relaxation [20] . These results led us to hypothesize that GVIA would disrupt the roscovitine-induced slowing of Off-gating current. Consistent with our prediction, we found that the roscovitine-induced effect was significantly decreased, and the voltage-dependence of the roscovitine effect was shifted + 32 mV by GVIA, which was larger than the effect of GVIA on the Q-V relationship (+10 mV). This difference likely reflects the profound impact of GVIA to destabilize the open state, since our modeling showed that additional changes to closedstate transitions did not affect the GVIA-induced right-shift of the voltage-dependent roscovitine effect on Off-gating current. However, the GVIA-induced reduction of τQ On could not be explained by our model in which we altered only open state-associated transition rates (GVIA1 model). This effect of GVIA required an additional effect on closed-state rate constants (GVIA2 model). We conclude that GVIA can affect both open state and closed-state transition rates, but the effect on open state rate constants primarily impacts roscovitineinduced slowed Off-gating current.
Model of N-channel gating
One of the primary predictions of our original N-channel model was that the channel would exhibit two open states during normal gating, and roscovitine would increase the mean open time by binding to the open state [16] . There was single channel evidence for two open states under normal conditions [25] , but there was no single channel data to support the roscovitine effect. This gap was recently closed with recordings from tsA201 cells stably expressing N-type channels showing that roscovitine increased the long open time, but not the short open time [19] . Thus, the essential features of the open state binding of roscovitine to slow N-channel closing have support from whole-cell, gating and single channel current recordings [16, 19, 20] .
Our gating current results motivated us to recently update our Nchannel model to include a voltage-independent transition between closed states along the pathway to channel opening [20] . The primary reason was that τQ Off reaches a voltage-independent plateau at voltages b−70 mV, which could not be modeled without introducing a voltage-independent transition. Unlike L-type channels [26] , we did not associate this transition with the open state since N-channel open times are voltage-dependent [27, 28] . However, single channel recording did identify a voltage-independent closed state that showed increased occupancy with depolarization as expected for a state near the open states [27] . Given this evidence we associated the voltageindependent rate constants with the closed-closed transition next to the first open state [20] . Besides the addition of closed states, the other major change with this new model was the general reduction in the magnitude of the forward rate constants between closed states (cf. [16, 20] ). This was required to increase the simulated τQ On to match that experimentally observed. These changes to the model required that we re-evaluate our previous conclusion that GVIA only affects the N-channel open state. We found that changes in the open state rate constants alone could not reproduce the toxin effect on τQ On , which was significantly reduced in our experimental results [15] . This lack of correspondence was not surprising since in developing the new model we had noticed that changes in the open state transitions had a relative minor effect on τQ On . Thus, additional increases in the backward rate constants between voltage-dependent closed states were required to provide good correspondence between our simulated and experimental results. This information permits us to expand our original hypothesis to suggest that GVIA alters gating by affecting N-channel open and closed states. Furthermore, our modeling suggests that many of these gating changes result from GVIA increasing the relaxation rate of all voltage sensors involved in N-channel activation, since all of the voltage-dependent backward rate constants are increased in our model (GVIA2).
Mechanism for the GVIA effect
Amino acid mutations within the extracellular loop between transmembrane segment 5 (S5) and the Pore-loop (P-loop) of domain Table 1 for model parameters) for depolarized voltages (N 0 mV). The simulations were done from a holding potential of −100 mV and 15-ms voltage steps to the indicated voltage. (B) The model nicely reproduces the effect of GVIA on τQ Off . Simulated gating currents were activated by 10-ms steps to 60 mV followed by 14-ms steps to the indicated voltage where τQ Off was measured. (C) τQ On was calculated using single exponential fits to the declining phase of the On-gating current from the same protocol used to generate the Q-V data (see panel A). τQ On is plotted vs. step voltage. The model fails to reproduce the reduction in τQ On induced by GVIA.
III alter the on-rate and off-rate for GVIA binding [11, 12] , which suggests that this region is important for toxin binding. We do not yet know the location of the roscovitine binding site on the N-channel to slow deactivation, but it seems clear from our data that toxin occupancy does not prevent roscovitine binding to the channel. An alternative possibility was that GVIA slows roscovitine binding so that we observe only a partial effect with our 10-15-ms voltage steps. There are several results that lead us to reject this possibility in favor of one where roscovitine binding is not altered. The first is that the right-shift in the Q-V relationship induced by roscovitine is not affected by GVIA. The second result is that the I Rosc /I Cntl ratio shows a maximal roscovitine effect on peak Off-gating current at step voltages ≥40 mV (Fig. 3B) , which suggests that further depolarization or duration of that depolarization will not increase the roscovitine effect. Thus, the evidence supports our conclusion that roscovitine can bind to a GVIA-occupied channel.
Regarding the potential mechanism by which GVIA alters N-channel gating, we previously presented two possibilities: allosteric modulation and electrostatic interaction with the voltage sensors [15] . Unfortunately, our data do not provide additional guidance to support firm mechanistic conclusions. We can conclude that the GVIA effect is not a simple surface charge screening effect as can be observed by altering external divalent cation concentration [29] . Surface charge screening is characterized by a shift in all voltage-dependent gating parameters (e.g. Boltzmann V 0.5 ) without an alteration in the voltage-dependence of those parameters (e.g. Boltzmann slope factor). A positively charged peptide derived from the sodium channel blocker μ-conotoxin GIIIA has been shown to modulate sodium channel gating by a surface charge screening mechanism [30] . However, GVIA increases the Boltzmann slope factor to spread charge movement over a wider voltage range than is observed under control (LaMg) conditions [15] . In addition, the voltage-dependence of τQ Off (Ve) is also reduced by GVIA [15] . Thus, the voltage-dependence of these gating parameters is altered by GVIA, which is contrary to predictions from a simple charge screening mechanism. It will be very interesting to investigate the effect of GVIA-related toxins (e.g. ω-conotoxin MVIIA and MVIIC), which have a different number of charged amino acid residues and could provide valuable insights into the mechanism (e.g. allosteric vs. electrostatic) by which N-channel targeted toxins modulate gating.
N-channel gating modulation: potential clinical implications
Our findings support our previous hypothesis that GVIA destabilizes the N-channel open state. Thus, researchers now have drugs available to either stabilize (roscovitine) or destabilize (GVIA) the open state, which can be used as probes to uncover critical new information regarding N-channel gating [15, 16, 19, 20] . In addition, these drugs may become lead compounds for the development of clinically effective treatments for diseases that could benefit from altered N-channel gating. Drugs like roscovitine could be helpful for treatment of diseases associated with decreased N-channel function. For example, it has been proposed that roscovitine-like drugs could be useful in the treatment of Lambert-Eaton myasthenia syndrome that is associated with a decrease in presynaptic CaV2 channels [31] , since roscovitine enhances action potential-induced calcium influx via these channels [16, 31] . The GVIA-related drug Prialt (ω-conotoxin MVIIA) is already an important drug for the treatment of chronic pain [6, 7, 9, 10] . However, some patients react poorly to Prialt, which supports the need for further research into new N-channel targeted blockers/gating modulators. The identification of novel drugs that mimic the GVIA effect on gating without blocking the pore could be an important breakthrough in this process. Much more work is needed, but the insights already gained from working with these gating modulators provides strong motivation for additional investigation.
